New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 24, 2014
09:55 EDTATHN, ATHN, IBM, IBM, INTC, INTCHouse Energy & Commerce Committee to hold a roundtable
The Committee holds its second 21st Century Cures Roundtable to discuss steps Congress can take to bridge the gap between advances and regulatory policies that govern them, ultimately advancing digital and personalized health care with SVP Hogan at IBM, Medical Director Blatt at Intel and CEO Bush of Athenahealth on June 24 at 10 am. Webcast Link
News For ATHN;IBM;INTC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 19, 2015
12:25 EDTINTCIntel sees FY16 revenue growth in the mid-single digits, consensus $57.48B
Subscribe for More Information
11:52 EDTINTCIntel sees Altera as accelerator of 'virtuous cycle'
Subscribe for More Information
11:41 EDTINTCIntel says Cloud is key growth area for Data Center
11:32 EDTINTCIntel says Tabet business is not a growth business
Subscribe for More Information
11:24 EDTINTCIntel targets FY15 revenue $55.2B, consensus $55.25B
Comments from Intel Investor Meeting.
07:43 EDTINTCHouse Energy & Commerce Committee to hold a hearing
The Commerce, Manufacturing and Trade Subcommittee holds a hearing entitled, "The Disrupter Series: The Fast-Evolving Uses & Economic Impacts of Drones" with Joshua Walden, Senior Vice President and General Manager of the New Technology Group at Intel on November 19 at 10:15 am. Webcast Link
November 18, 2015
13:44 EDTINTCBefore the Move: Watch Intel into tomorrow's analyst day
Chipmaker Intel's (INTC) analyst day tomorrow could yield information on numerous company operations, but Jefferies analyst Mark Lipacis cautions investors that the probability for positive surprises appears low given recent spending outlays. BACKGROUND: Intel, one of the largest semiconductor makers in the world, is scheduled to hold an analyst day on Thursday, November 19. Beyond providing forecasts for its various business segments and remarks on the larger computer market, Intel is expected to provide further clarity on several recent stories, including its memory joint venture with Micron (MU), plans to invest heavily in a Chinese production facility and progression towards chips on the 10 nanometer scale. STRONG OUTLOOK, MILD MEETING: Intel's pending acquisition of Altera (ALTR) and its plans to invest as much as $5.5B in a computer memory facility in Dalian, China leave little room for positive surprises at tomorrow's event in regards to 2016 margins, capital expenditures, or shareholder returns, Jefferies analyst Mark Lipacis said in a recent research note. That said, the analyst views Intel's Chinese facility expansion as part of a "brilliant investment strategy that positions Intel as a partner to China" and "keeps the market open" to its microprocessors, perhaps Intel's more famed business segment. Though the two initiatives are certain to push up near-term debt load, Lipacis takes the longer-term view, reminding investors that Intel has shown consistently strong free cash flow over the past decade, leading him to forecast another $13B in 2016. The year may also bring "a number" of other positives for the company, including more data center wins after the Altera tie-up, potentially renewed sales on a cyclical uptick in PC gaming, and even the possibility of an iPhone chip contract, though Lipacis said none of those points look set to be discussed tomorrow. The analyst kept a Buy rating and $38 price target on the shares while reiterating that Thursday's Intel event may have little in store for those expecting eye-grabbing surprises. PRICE ACTION: Shares of Intel have advanced roughly 0.9% to $32.92 Wednesday afternoon. "Before the Move" is The Fly's recurring series of exclusive stories that identify potentially market moving events, along with analyst predictions, ahead of the news.
November 17, 2015
15:40 EDTINTCIntel to host investor meeting
Subscribe for More Information
15:02 EDTATHNathenahealth announced new services agreement with TeamPraxis
athenahealth and TeamPraxis, a physician service organization in Hawaii, announced a new services agreement which enables TeamPraxis to access and use the athenaNet platform to implement and support the athenaOne suite of services and athenaCommunicator Enterprise population health service.
11:23 EDTATHNBarclays says sell athenahealth as new customers get harder to find
Barclays downgraded athenahealth (ATHN) to Underweight, the firm's equivalent of a Sell rating, in a note to investors today. The company's prospects in the ambulatory care market look weak and its growth rate appears to be unsustainable, the firm contended. athenahealth provides cloud-based services and mobile applications to medical groups WHAT'S NEW: After analyzing the ambulatory enterprise market, Barclays analyst Eric Percher reported that only 12 of the 100 largest names on the list are potential targets for athenahealth. Additionally, those dozen groups are much smaller than the ones with which athenahealth made deals in 2014 and earlier this year, wrote Percher. Given his findings, the analyst expects athenahealth's revenue growth to decline going forward. In order to accelerate its growth, athenahealth needs large contract wins and those are unlikely to occur in the near-term, predicted the analyst, who downgraded the stock to Underweight from Equal Weight and lowered his price target on the name to $110 from $140. WHAT'S NOTABLE: JPMorgan analyst Michael Newshel assumed lead coverage of athenahealth today with an Overweight rating and $170 price target. In his note this morning on the space, Newshel said his firm's latest hospital CIO survey indicates there will be no slowdown in HIT investments despite the electronic health records adoption cycle maturing. PRICE ACTION: In morning trading, athenahealth fell 6.6% to $152.22.
11:03 EDTINTCTsinghua Chairman says in talks with U.S.-based chipmaker, Reuters reports
Subscribe for More Information
10:00 EDTATHNOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Airgas (ARG) downgraded on valuation at KeyBanc... BHP Billiton (BHP) downgraded to Neutral from Buy at Clarksons Platou... Chesapeake (CHK) downgraded to Neutral from Buy at Sterne Agee CRT... ChipMOS (IMOS) downgraded to Equal Weight from Overweight at Morgan Stanley... Clovis (CLVS) downgraded to Neutral from Conviction Buy at Goldman... Cooper Companies (COO) downgraded to Market Perform from Outperform at Wells Fargo... Five Below (FIVE) downgraded to Neutral from Buy at Sterne Agee CRT... Grainger (GWW) downgraded to Underweight from Neutral at Atlantic Equities... Hess Corp. (HES) downgraded to Perform from Outperform at Oppenheimer... J Sainsbury (JSAIY) downgraded to Neutral from Buy at Citi... Kindred Biosciences (KIN) downgraded to Market Perform from Outperform at BMO Capital... Leju (LEJU) downgraded to Neutral from Buy at BofA/Merrill... Lombard Medical (EVAR) downgraded to Equal Weight from Overweight at Barclays... Osiris (OSIR) downgraded to Sell from Hold at Brean Capital... Polaris Industries (PII) downgraded on anemic ORV growth at Wedbush... SQM (SQM) downgraded to Hold from Buy at HSBC... Southwestern Energy (SWN) downgraded to Underperform from Neutral at Sterne Agee CRT... Starwood (HOT) downgraded to Outperform from Buy at CLSA... Urban Outfitters (URBN) downgraded to Hold from Buy at Cantor... WM Morrison (MRWSY) downgraded to Sell from Neutral at Citi... adidas (ADDDY) downgraded to Sector Perform from Outperform at RBC Capital... athenahealth (ATHN) downgraded to Underweight from Equal Weight at Barclays.
07:48 EDTINTCHP Enterprise announces alliance with Intel
Subscribe for More Information
06:31 EDTIBMBerkshire buys more IBM shares, WSJ says
Subscribe for More Information
06:27 EDTINTCIntel November volatility elevated into investor meeting
Subscribe for More Information
06:26 EDTATHNThe Advisory Board initiated with an Overweight at JPMorgan
Subscribe for More Information
05:43 EDTATHNathenahealth downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Eric Percher downgraded athenahealth to Underweight saying the company's physician and revenue growth will decline moving forward. An analysis of the ambulatory enterprise market indicates that potential athenahealth targets among the 100 largest health systems number only 12, Percher tells investors in a research note. Big enterprise wins are needed to drive growth but are "few and far between," the analyst contends. He cut his price target for athenahealth to $110 from $140. The provider of cloud-based services for medical groups and health systems closed yesterday up $1.77 to $162.98.
November 16, 2015
09:37 EDTINTCActive equity options trading on open
Active equity options trading on open: AAPL FB ORCL BAC SUNE FDX FCX EXPE NFLX MU AMZN INTC TSLA
07:50 EDTIBMUBS to hold a conference
Subscribe for More Information
05:42 EDTIBMXilinx, IBM announce strategic collaboration
IBM (IBM), and Xilinx (XLNX) announced a multi-year strategic collaboration to enable higher performance and energy-efficient data center applications through Xilinx FPGA-enabled workload acceleration on IBM POWER-based systems. IBM and Xilinx, through a private signed agreement and collaboration through the OpenPOWER Foundation, are teaming to develop open acceleration infrastructures, software and middleware to address emerging applications such as machine learning, network functions virtualization, or NFV, genomics, high performance computing, or HPC, and big data analytics. As part of the IBM and Xilinx strategic collaboration, IBM Systems Group developers will create solution stacks for POWER-based servers, storage and middleware systems with Xilinx FPGA accelerators for data center architectures such as OpenStack, Docker, and Spark. IBM will also develop and qualify Xilinx accelerator boards into IBM Power Systems servers. Xilinx is developing and will release POWER-based versions of its leading software defined SDAccel Development Environment and libraries for the OpenPOWER developer community. Additionally, IBM and Xilinx will continue to further utilize IBM's innovative Coherent Accelerator Processor Interface, or CAPI, to deliver accelerated computing value to its clients. CAPI, a unique feature built into the POWER architecture, provides Xilinx and the technology industry at large with the ability to build tightly integrated, coherent solutions right on top of the POWER architecture.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use